Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Phase II Study of a JAK1/2 Inhibitor Ruxolitinib for Systemic Chronic Active Epstein-Barr Virus Disease: An Investigator-Initiated Trial

Yu Uemura, Masahide Yamamoto, Masataka Ishimura, Hirokazu Kanegane, Akihisa Sawada, Akihiro Hirakawa, Ken-Ichi Imadome, Mayumi Yoshimori, Masashi Nagata, Norio Shimizu, Ryuji Koike, Ayako Arai

Blood (2022) 140 (Supplement 1): 6571–6572.

https://doi.org/10.1182/blood-2022-168565

Published: 2022

Journal Articles

The Outcomes of Systemic Chronic Active EBV Infection Treatment By Allogeneic Hematopoietic Stem Cell Transplantation: An Analysis of Japanese Registry Data

Blood (2021) 138 (Supplement 1): 3965.

https://doi.org/10.1182/blood-2021-147046

Published: 2021

Journal Articles

A Nationwide Survey on Chronic Active Epstein-Barr Virus Infection in Japan Based on New Diagnostic Criteria: Clinical Features and Treatment Strategies

Ayako Arai, MD PhD, Ichiro Yonese, Chizuko Sakashita, MD PhD, Ken-Ichi Imadome, PhD, Tohru Kobayashi, MD PhD, Akihisa Sawada, MD PhD, Yoshinori Ito, MD PhD, Shouichi Ohga, MD PhD, Hiroshi Kimura, MD, Ph. D., Shigeyoshi Fujiwara, MD, PhD

Blood (2018) 132 (Supplement 1): 1631.

https://doi.org/10.1182/blood-2018-99-117854

Published: 2018

Journal Articles

The Presence of Defective Epstein-Barr Virus (EBV) Infection in Patients with EBV-Associated Hematological Malignancy

Yusuke Okuno, MDPhD, Takayuki Murata, MD, PhD, Yoshitaka Sato, MD, PhD, Hideki Muramatsu, MD PhD, Yoshinori Ito, MD PhD, Takahiro Watanabe, D.MD, PhD, Tatsuya Okuno, MD, Norihiro Murakami, MD, Kenichi Yoshida, MD PhD, Akihisa Sawada, MD PhD, Masami Inoue, MD, Keisei Kawa, MD, PhD, Masao Seto, MD PhD, Koichi Ohshima, MDPhD, Yuichi Shiraishi, PhD, Kenichi Chiba, PhD, Hiroko Tanaka, BA, Satoru Miyano, PhD, Yohei Narita, PhD, Masahiro Yoshida, MD PhD, Fumi Goshima, PhD, Junichi Kawada, MD PhD, Tetsuya Nishida, MD PhD, Hitoshi Kiyoi, MD PhD, Seiichi Kato, MD, PhD, Shigeo Nakamura, MD PhD, Satoko Morishima, MD PhD, Shigeyoshi Fujiwara, MD, PhD, Norio Shimizu, PhD, Yasushi Isobe, MD, PhD, Masaaki Noguchi, MD, PhD, Atsushi Kikuta, MD, Keiji Iwatsuki, MD, PhD, Yoshiyuki Takahashi, MD, PhD, Seiji Kojima, MD PhD, Seishi Ogawa, MD PhD, Hiroshi Kimura, MD, Ph. D.

Blood (2018) 132 (Supplement 1): 1562.

https://doi.org/10.1182/blood-2018-99-113801

Published: 2018

Journal Articles

Coagulation and Fibrinolysis Imbalance Demonstrated By Novel Simultaneous Thrombin and Plasmin Generation Assay during L-Asparaginase Treatment Phase of Induction Therapy in Pediatric Acute Lymphoblastic Leukemia

Takashi Ishihara, MD, Keiji Nogami, MD PhD, Satoshi Ochi, MD, Toshiaki Ishida, MD PhD, Yoshiyuki Kosaka, MD PhD, Akihisa Sawada, MD PhD, Masami Inoue, MD, Shinya Osone, MD PhD, Toshihiko Imamura, MD PhD, Hajime Hosoi, MD PhD, Midori Shima, MD PhD

Blood (2018) 132 (Supplement 1): 3972.

https://doi.org/10.1182/blood-2018-99-110411

Published: 2018

Journal Articles

Genetic Background of Chronic Active Epstein-Barr Virus Disease

Yusuke Okuno, MD PhD, Takayuki Murata, MD, PhD, Yoshitaka Sato, MD, PhD, Hideki Muramatsu, MD PhD, Norihiro Murakami, MD, Tatsuya Okuno, MD, Kenichi Yoshida, MD PhD, Yoshinori Ito, MD PhD, Akihisa Sawada, MD PhD, Koichi Ohshima, MDPhD, Yuichi Shiraishi, PhD, Kenichi Chiba, B.A., Hiroko Tanaka, B.A., Satoru Miyano, PhD, Yoshiyuki Takahashi, MD PhD, Seiji Kojima, MD PhD, Seishi Ogawa, MD PhD, Hiroshi Kimura, MD, Ph. D.

Blood (2017) 130 (Supplement 1): 1468.

https://doi.org/10.1182/blood.V130.Suppl_1.1468.1468

Published: 2017

Journal Articles

Shift to Anti-Fibrinolysis on the Administration of L-Asparaginase (L-Asp) during Induction Therapy for Pediatric Acute Lymphoblastic Leukemia (ALL)

Takashi Ishihara, MD, Keiji Nogami, MD PhD, Tomoko Matsumoto, PhD, Yasufumi Takeshita, MD, Akitaka Nomura, MD, Satoshi Ochi, MD, Toshiaki Ishida, MD PhD, Yoshiyuki Kosaka, MD PhD, Akihisa Sawada, PhD MD, Masami Inoue, MD, Midori Shima, MD PhD

Blood (2016) 128 (22): 5156.

https://doi.org/10.1182/blood.V128.22.5156.5156

Published: 2016

Journal Articles

MRD-Based Strategy without Myeloablative Transplantation for AML in Children

Akihisa Sawada, PhD MD, Sadao Tokimasa, PhD MD, Masahiro Yasui, MD, Maho Koyama-Sato, PhD MD, Mariko Shimizu, MD, Kohei Higuchi, MD, Azusa Mayumi, MD, Aya Ioi, MD, Keisei Kawa, PhD MD, Masami Inoue, MD

Blood (2015) 126 (23): 3738.

https://doi.org/10.1182/blood.V126.23.3738.3738

Published: 2015

Journal Articles

Encouraging Outcomes of Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Pediatric Patients with Acute Lymphoblastic Leukemia in Second Complete Remission

Kohei Higuchi, MD, Maho Sato, MD PhD, Osamu Kondo, MD, Aya Ioi, MD, Azusa Mayumi, MD, Mariko Shimizu, MD, Akihisa Sawada, MD PhD, Masahiro Yasui, MD, Masami Inoue, MD

Blood (2014) 124 (21): 5933.

https://doi.org/10.1182/blood.V124.21.5933.5933

Published: 2014

Journal Articles

Adverse Impact Of Elevated Pretransplantation Serum Ferritin Levels On Survival and Nonrelapse Mortality After Allogeneic Hematopoietic Stem Cell Transplantation In Children

Osamu Kondo, MD, Kohei Higuchi, MD, Mariko Shimizu, MD, Azusa Mayumi, MD, Kanako Isaka, MD, Akihisa Sawada, MD, PhD, Maho Sato, MD, Masahiro Yasui, MD, Masami Inoue, MD, PhD

Blood (2013) 122 (21): 2168.

https://doi.org/10.1182/blood.V122.21.2168.2168

Published: 2013

Journal Articles

EBV-associated T/NK–cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases

Hiroshi Kimura, Yoshinori Ito, Shinji Kawabe, Kensei Gotoh, Yoshiyuki Takahashi, Seiji Kojima, Tomoki Naoe, Shinichi Esaki, Atsushi Kikuta, Akihisa Sawada, Keisei Kawa, Koichi Ohshima, Shigeo Nakamura

Blood (2012) 119 (3): 673–686.

https://doi.org/10.1182/blood-2011-10-381921

Published: 2012

Includes: Supplemental data

Journal Articles

Serious Late Complications After Hematopoietic Stem Cell Transplantation (HSCT) Following Myeloablative Conditioining (MAC) In Infants.

Masahiro Yasui, MD, Kayo Yamada, MD, Osamu Kondo, MD, Maho Sato, MD, Akihisa Sawada, MD, Sadao Tokimasa, MD, Keisei Kawa, MD, Masami Inoue, MD

Blood (2010) 116 (21): 4501.

https://doi.org/10.1182/blood.V116.21.4501.4501

Published: 2010

Journal Articles

Encouraging Results of Reduced-Intensity Conditioning (RIC) Followed by Hematopoietic Stem Cell Transplantation (HSCT) from an Alternative Donor for Acute Lymphoblastic Leukemia (ALL) In Children.

Masami Inoue, MD, Masahiro Yasui, MD, Sadao Tokimasa, MD, PhD, Akihisa Sawada, MD, PhD, Maho Sato, MD, PhD, Osamu Kondo, MD, Kayo Yamada, MD, Keisei Kawa, MD, PhD

Blood (2010) 116 (21): 4572.

https://doi.org/10.1182/blood.V116.21.4572.4572

Published: 2010

Journal Articles

Long-Term Survival after HLA-Haploidentical Stem Cell Transplantation from Non-Inherited Maternal Antigen-Mismatched Family Donors: Impact of Chronic Graft-Versus-Host Disease.

Tatsuo Ichinohe, MD, Chihiro Shimazaki, MD, Motohiro Hamaguchi, MD, Arata Watanabe, MD, Hiroyuki Ishida, MD, Takao Yoshihara, MD, Akira Morimoto, MD, Nobuhiko Uoshima, MD, Souichi Adachi, MD, Takeshi Inukai, MD, Akihisa Sawada, MD, Koji Oka, MD, Mitsuru Itoh, MD, Masayuki Hino, MD, Junya Kanda, MD, Takashi Uchiyama, MD, Yoshihisa Kodera, MD

Blood (2007) 110 (11): 5075.

https://doi.org/10.1182/blood.V110.11.5075.5075

Published: 2007

NARROW

Phase II Study of a JAK1/2 Inhibitor Ruxolitinib for Systemic Chronic Active Epstein-Barr Virus Disease: An Investigator-Initiated Trial

The Outcomes of Systemic Chronic Active EBV Infection Treatment By Allogeneic Hematopoietic Stem Cell Transplantation: An Analysis of Japanese Registry Data

A Nationwide Survey on Chronic Active Epstein-Barr Virus Infection in Japan Based on New Diagnostic Criteria: Clinical Features and Treatment Strategies

The Presence of Defective Epstein-Barr Virus (EBV) Infection in Patients with EBV-Associated Hematological Malignancy

Coagulation and Fibrinolysis Imbalance Demonstrated By Novel Simultaneous Thrombin and Plasmin Generation Assay during L-Asparaginase Treatment Phase of Induction Therapy in Pediatric Acute Lymphoblastic Leukemia

Genetic Background of Chronic Active Epstein-Barr Virus Disease

Shift to Anti-Fibrinolysis on the Administration of L-Asparaginase (L-Asp) during Induction Therapy for Pediatric Acute Lymphoblastic Leukemia (ALL)

MRD-Based Strategy without Myeloablative Transplantation for AML in Children

Encouraging Outcomes of Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Pediatric Patients with Acute Lymphoblastic Leukemia in Second Complete Remission

Adverse Impact Of Elevated Pretransplantation Serum Ferritin Levels On Survival and Nonrelapse Mortality After Allogeneic Hematopoietic Stem Cell Transplantation In Children

EBV-associated T/NK–cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases

Serious Late Complications After Hematopoietic Stem Cell Transplantation (HSCT) Following Myeloablative Conditioining (MAC) In Infants.

Encouraging Results of Reduced-Intensity Conditioning (RIC) Followed by Hematopoietic Stem Cell Transplantation (HSCT) from an Alternative Donor for Acute Lymphoblastic Leukemia (ALL) In Children.

Long-Term Survival after HLA-Haploidentical Stem Cell Transplantation from Non-Inherited Maternal Antigen-Mismatched Family Donors: Impact of Chronic Graft-Versus-Host Disease.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only